S2E32: Geriatric Psychopharmacology for PMHNPs: Safe Prescribing for Older Adults

S2E58: Modern Lithium Monitoring: The 2026 PMHNP Protocol

In this deep-dive episode, we unpack Modern Lithium Monitoring: The 2026 PMHNP Protocol. Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. TL;DR Lithium remains the gold standard for bipolar maintenance and suicide prevention, but the 2026 monitoring protocol has evolved. New PMHNPs should narrow the maintenance target to 0.6-0.8 mEq/L, draw trough levels exactly 12 hours post-dose, screen every patient for GLP-1 agonist use before starting lithium, and coach hydration and sodium behavior as part of the monitoring plan. This post walks through the complete modern protocol — baseline workup, dosing strategy, draw timing, red flags, and the medication interactions that matter most right now. In This Guide Why Lithium Still Wins in 2026 The 2026 Baseline Workup Dosin Read the full post: https://psychnpfellowship.com/lithium-monitoring-protocol-pmhnp-2026/

S2E57: PMHNP Insurance Credentialing: Cut the 120-Day Wait to 45

In this deep-dive episode, we unpack PMHNP Insurance Credentialing: Cut the 120-Day Wait to 45. Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. TL;DR Insurance credentialing for a new PMHNP usually takes 90 to 150 days per payer. A 16-week gap between diploma and first insurance check can cost $60,000 in delayed revenue. Five pre-application moves compress most timelines to 45-60 days. Supervision-required states (TX, FL, PA, others) add a separate approval step. Plan for it. California’s AB 890 independent-practice phase-in is live in 2026. The credentialing packet changed with it. The biggest revenue leak is not the wait. It’s the re-attestation lapse at day 121. In This Post Why the 120-Day Timeline Exists The Real Cost of Waiting The Five Pre-Application Moves What Read the full post: https://psychnpfellowship.com/pmhnp-insurance-credentialing-timeline-2026/

S2E56: Handling Patient Pushback: A New PMHNP’s Confidence Playbook

In this deep-dive episode, we unpack Handling Patient Pushback: A New PMHNP’s Confidence Playbook. Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. TL;DR. New PMHNPs rarely fail because of pharmacology gaps. They stumble when a patient pushes back and the clinician freezes, over-explains, or caves. This playbook shows a 3-step script — Acknowledge, Anchor, Advance — that holds clinical ground, protects the therapeutic alliance, and builds confidence in 60 to 90 days. Includes what most new grads get wrong, a named Fellowship drill, and a 6-question FAQ. In this article Why Patient Pushback Breaks New PMHNPs The Triple-A Script: Acknowledge, Anchor, Advance What Most People Get Wrong About Patient Pushback Four Pushback Scenarios and How to Handle Each The Weekly Debrief Dr Read the full post: https://psychnpfellowship.com/handling-patient-pushback-new-pmhnp-confidence-playbook/

S2E55: Pramipexole for Treatment-Resistant Depression: What PMHNPs Should Know

In this deep-dive episode, we unpack Pramipexole for Treatment-Resistant Depression: What PMHNPs Should Know. Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. TL;DR Pramipexole (Mirapex), a dopamine D3 receptor agonist FDA-approved for Parkinson’s disease, showed strong results in the PAX-D trial published in The Lancet Psychiatry for treatment-resistant unipolar depression. At a target dose of 2.5 mg/day added to existing antidepressants, patients saw significant symptom reduction by week 12, with benefits lasting through 48 weeks. PMHNPs should know the titration protocol, watch for impulse control disorders and nausea, and understand where this fits in the treatment algorithm after two or more failed antidepressant trials. In This Article Why Dopamine Matters in Treatment-Resistan Read the full post: https://psychnpfellowship.com/pramipexole-treatment-resistant-depression-pmhnp-guide/

S2E54: PMHNP Subspecialties: 4 Certifications Worth Pursuing in 2026

In this deep-dive episode, we unpack PMHNP Subspecialties: 4 Certifications Worth Pursuing in 2026. Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. TL;DR The PMHNP-BC opens doors, but subspecialty certifications open better ones. In 2026, four advanced credentials — CARN-AP (addiction), PMH-C (perinatal), PMHS (pediatric), and CPRP (psychiatric rehabilitation) — are creating salary bumps, sharper clinical confidence, and access to specialized roles that generalist PMHNPs can’t touch. This post breaks down each certification, what it takes to earn them, and why early-career PMHNPs should start thinking about specialization now rather than later. In This Post Why Subspecialization Matters Now CARN-AP: Addiction Nursing for Advanced Practice PMH-C: Perinatal Mental Health Cer Read the full post: https://psychnpfellowship.com/pmhnp-subspecialty-certifications-2026/